A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.
Warner and Tim Kaine (both D-VA) recently celebrated a provision of the Inflation Reduction Act that will go into effect on January 1, 2025 to cap out-of-pocket costs for prescription drugs at $2,000 ...